BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 32957757)

  • 21. [Predictive value of four score systems on the bleeding risk in atrial fibrillation patients treated with dabigatran].
    Ding CC; Zhan BM; Zhou W; Li MH; Hu LH; Bao HH; Cheng XS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Sep; 48(9):748-752. PubMed ID: 32957757
    [No Abstract]   [Full Text] [Related]  

  • 22. Dabigatran for stroke prevention in nonvalvular atrial fibrillation: focus in the geriatric population.
    Brunetti L; Chen C; White J
    Consult Pharm; 2014 Mar; 29(3):169-78. PubMed ID: 24589766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance of the HAS-BLED high bleeding-risk category, compared to ATRIA and HEMORR2HAGES in patients with atrial fibrillation: a systematic review and meta-analysis.
    Caldeira D; Costa J; Fernandes RM; Pinto FJ; Ferreira JJ
    J Interv Card Electrophysiol; 2014 Sep; 40(3):277-84. PubMed ID: 25012972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The HAS-BLED Score for Predicting Major Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: A Systematic Review and Meta-analysis.
    Zhu W; He W; Guo L; Wang X; Hong K
    Clin Cardiol; 2015 Sep; 38(9):555-61. PubMed ID: 26418409
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 26.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.